Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Arcus Biosciences, Inc. |
| AGRANT◆ |
| 16,900 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 11 | RCUS | Arcus Biosciences, Inc. | AGRANT | 5,700 | — | — | +14.8% | Open the original filing on SEC.gov |
| Jun 3 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 1,593 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | XENE | Xenon Pharmaceuticals Inc. | AGRANT◆ | 10,507 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | XENE | Xenon Pharmaceuticals Inc. | MEXER◆ | 2,645 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | XENE | Xenon Pharmaceuticals Inc. | MEXER | 2,645 | — | — | — | Open the original filing on SEC.gov |